Avatrombopag 10 MG Oral Granules — RxCUI 2721188
RxNorm drug concept · Semantic clinical drug
RxCUI 2721188
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2721188
Official nameAvatrombopag 10 MG Oral Granules
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asavatrombopag 10 MG (equivalent to avatrombopag maleate 11.787 MG) Oral Granules
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,342 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Avatrombopag: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Your platelet count is too low, which means your blood can't clot properly and you're at higher risk for serious bleeding. Avatrombopag works by telling your bone marrow to make mo...
- What exactly is this medicine doing for me — why do I need it?
- Yes, every dose — whether it's the tablet or the Doptelet Sprinkle granules — needs to be taken with food. Food helps the medicine absorb properly. If you're using Doptelet Sprinkl...
- Do I have to take it with food every time?
🕸️ Concept Web — How Avatrombopag 10 MG Oral Granules Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Avatrombopag 10 MG Oral Granules
RxCUI 2721188 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Avatrombopag
2045726IN
-
Avatrombopag
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Doptelet
2045953BN
-
Doptelet
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Avatrombopag Oral Granules
2721187SCDF -
Avatrombopag Granule Product
2721186SCDG -
Avatrombopag Oral Product
2045948SCDG -
Avatrombopag Oral Granules [Doptelet]
2721191SBDF -
Doptelet Granule Product
2721190SBDG -
Doptelet Oral Product
2045956SBDG -
Oral Granules
317690DF -
Granule Product
1294708DFG - +1 more in this family
-
Avatrombopag Oral Granules
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Avatrombopag 10 MG
2721185SCDC -
Avatrombopag 10 MG Oral Granules [Doptelet]
2721192SBD -
Avatrombopag 10 MG [Doptelet]
2721189SBDC
-
Avatrombopag 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Avatrombopag 10 MG
SCDC · 2721185 -
Avatrombopag Oral Granules
SCDF · 2721187 -
Avatrombopag Granule Product
SCDG · 2721186 -
Avatrombopag Oral Product
SCDG · 2045948
Brand-Name Concepts
-
Avatrombopag 10 MG Oral Granules [Doptelet]
SBD · 2721192 -
Avatrombopag 10 MG [Doptelet]
SBDC · 2721189 -
Avatrombopag Oral Granules [Doptelet]
SBDF · 2721191 -
Doptelet Granule Product
SBDG · 2721190 -
Doptelet Oral Product
SBDG · 2045956 -
Doptelet
BN · 2045953
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2721188 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71369-0010-30 | 1 BOTTLE in 1 CARTON (71369-010-30) / 30 GRANULE in 1 BOTTL... | Doptelet Sprinkle | AkaRx, Inc. | 2025-07-25 |
| 71369-0020-10 | 1 BLISTER PACK in 1 CARTON (71369-020-10) / 10 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2018-05-23 |
| 71369-0020-15 | 1 BLISTER PACK in 1 CARTON (71369-020-15) / 15 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2018-05-23 |
| 71369-0020-30 | 2 BLISTER PACK in 1 CARTON (71369-020-30) / 15 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2019-06-26 |
Observed labelers:
AkaRx, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.